Toward quality assessment of 3D printed oral dosage forms
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Toward quality assessment of 3D printed oral dosage forms. / Markl, Daniel; Zeitler, Axel; Rades, Thomas; Rantanen, Jukka; Bøtker, Johan.
In: Journal of 3D Printing in Medicine, Vol. 2, No. 1, 15.12.2017, p. 27-33.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Toward quality assessment of 3D printed oral dosage forms
AU - Markl, Daniel
AU - Zeitler, Axel
AU - Rades, Thomas
AU - Rantanen, Jukka
AU - Bøtker, Johan
N1 - doi: 10.2217/3dp-2017-0016
PY - 2017/12/15
Y1 - 2017/12/15
N2 - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.
AB - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.
U2 - 10.2217/3dp-2017-0016
DO - 10.2217/3dp-2017-0016
M3 - Tidsskriftartikel
VL - 2
SP - 27
EP - 33
JO - Journal of 3 D Printing in Medicine
JF - Journal of 3 D Printing in Medicine
SN - 2059-4755
IS - 1
ER -
ID: 189765191